A global maternal immunization program for group B Streptococcus -- strep B -- would save millions in healthcare costs by reducing death and disability, but without tiered pricing, equitable access would likely not be achieved. Several vaccines are currently under development, and an assessment of the impact and value of a global program has now been published.
